Those who take Ozempic or Wegovy may have an increased risk of developing a rare form of blindness, though future research is ...
Popular weight loss and type two diabetes drugs like Ozempic and Wegovy have been linked to an increased risk of a rare form ...
Weight loss drugs may increase the risk of blindness. Study finds a link between semaglutide and NAION, a rare eye condition ...
A study links semaglutide (the ingredient in Ozempic) with an increased risk for a rare eye disease, but that's not the full ...
Patients prescribed semaglutide for diabetes and weight loss may have a higher risk of a potentially blinding eye disease. | ...
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk ...
People using semaglutide to treat diabetes or lose weight may be at higher risk of developing a condition that causes sudden ...
For patients with Type 2 diabetes, taking one of the new GLP-1 drugs, such as Ozempic, is associated with lower risks of ...
The use of semaglutide drugs, like Wegovy and Ozempic, may have an increased risk of sudden and irreversible vision loss and blindness, the study found.
Patients prescribed semaglutide for diabetes or weight loss had a higher risk of having a potentially blinding eye condition, ...
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
Scientists have issued a warning as a concerning new study has linked a popular diabetes medication also used by some ...